菜单 关闭

新闻与活动

The latest news about Lazarex Cancer Foundation’s programs and advocacy efforts.

Lazarex新闻图标
< 时间轴 >
2月 28, 2024
Cancer Hope Network Announces One-On-One Peer Mentorship Collaboration with Lazarex Cancer Foundation: Cancer Hope Network and Lazarex Cancer Foundation announced today a new collaboration that will expand patient and caregiver access to psychosocial support during clinical trials through Cancer Hope Network’s Talking About Clinical Trials (TACT) program.
了解更多
2月 25, 2024
Fox News: Lazarex Cancer Foundation founder Dana Dornsife joins ‘Fox News 星期日’ to discuss how her new children’s book aims to inspire African American children to become doctors.
了解更多
2月 22, 2024
How Louisiana cancer patients navigate the ‘hidden’ costs of participating in clinical trials. For cancer patients, clinical trials can come with significant out-of-pocket costs. PBS News Hour interviews Lazarex VIP Shenard Matthews and Founder Dana Dornsife.
了解更多
2月 2024 Newsletter
Lazarex Cancer Foundation update from our founder, Dana Dornsife, 7th annual 5.44K registration open, hear from Lazarex VIP Tiffany Collins, children’s book Willis Watson is a Wannabe hits bookstores on 2月 27, So CA Lazarex Cancer Wellness HUB in the community update…
了解更多
< 时间轴 >
12月 12, 2023
McKinney man helped by cancer non-profit hopes to encourage other People of Color: When Vernell Brown of McKinney found out he had cancer, the 62-year-old nurse became a patient and kept his diagnosis a secret from his family for months. With Vernell Brown (Lazarex patient) and Dana Dornsife, Lazarex founder.
了解更多
11月 7, 2023
Listening to America – Cancer Clinical Trials: video broadcast with Shenard Matthews, a Lazarex Cancer Foundation very important patient, and Dana Dornsife, Lazarex founder, about cancer health disparities and the need for diversity in cancer clinical trials.
了解更多
9月 28, 2023
Lazarex Cancer Foundation Founder Receives Champion for Cures Award From Leaders of 100+ Cancer Centers. The Association of American Cancer Institutes (AACI) has chosen Dana Dornsife, founder and Chief Mission and Strategy Officer of Lazarex Cancer Foundation, to receive its distinguished 2023 Champion for Cures Award.
了解更多
八月 31, 2023
Leading with empathy: Foundation drives equitable outcomes for cancer patients: San Francisco Business Times interviews Lazarex Founder Dana Dornsife and Lazarex CEO Stephanie Rivera.
了解更多
八月 9, 2023
Christina Daves Ageless & Bold podcast: Navigating Clinical Trials and Cancer Patient Advocacy with Dana Dornsife. In this episode, Dana shares valuable resources and tips on how to advocate for cancer patients effectively.
了解更多
6月 19, 2023
On 6月 6, 2023, Disrupting the System VI was held on Capitol Hill in Washington, D.C., marking 6 years of hosting provocative conversations to drive equity, improve access and promote change to cancer care. This year’s focus was identifying practical ways to level the playing field when it comes to cancer health disparities, patient access and outcomes – with a focus on genomic testing and health insurance. Read the summary…
了解更多
5月 2, 2023
New Georgia law will reimburse cancer patients for their participation in trials: Governor Brian Kemp signed SB223 into law 星期二. The legislation, now paves the way for trial sponsors, like hospitals, pharmaceutical companies, and non-profits, to reimburse cancer patients for the costs they incur by participating in trials.
了解更多
三月 30, 2023
Lazarex Cancer Foundation Receives the Inaugural Glen De Vries Epic Award commemorating Medidata’s co-founder, who inspired others to create transformational change: Lazarex Cancer Foundation focuses on improving cancer health outcomes, cancer clinical trial diversity and enrollment, and patient access to care. “I love what Glen has created in Medidata and I am so honored to receive this award in his memory,” said Dana Dornsife, CEO and Founder of the Lazarex Cancer Foundation. “It was clear at NEXT that Medidata and its partners appreciate that patients come first, and so I want to thank Medidata for helping us help them.”
了解更多
三月 27, 2023
Medical Gaslighting of Women is Real and So is its Toll: It happened to Serena Williams. It recently happened to my friend Stephanie Rivera, the CEO of Lazarex Cancer Foundation. It’s also happened to me. It’s medical gaslighting — dismissing, downplaying or not believing patients when they share their symptoms in a healthcare setting. By Marya Shegog, Health Equity and Diversity Director for Lazarex Cancer Foundation.
了解更多
三月 23, 2023
Lazarex Cancer Foundation Among Honorees for #GameChangers Award: Eight innovative companies from California will be honored at Innovation Tri-Valley Leadership Group’s 2023 #GameChangers Awards next week. The annual awards ceremony brings together founders, mentors, stakeholders and influencers from the Bay Area for a night that honors local companies and leaders for their ground-breaking solutions to different issues in the world.
了解更多
2月 27, 2023
The MMRF and Lazarex Cancer Foundation Partner to Improve Equitable Access to Myeloma Clinical Trials: As part of the partnership, the MMRF contributed $100,000 to Lazarex’s PATH Program, a service designed to improve enrollment and diversity in clinical trials through patient reimbursement of out-of-pocket travel costs, community outreach, and engagement.
了解更多
2023 年 2 月 10 日
安-帕斯曼尼克(Ann Pasmanick)在 "Power Station "播客中采访了 Lazarex 癌症基金会创始人兼首席使命和战略官丹娜-多恩西弗(Dana Dornsife),介绍了 LCF 的项目、宣传以及在癌症健康和获得护理方面为种族和社区公平所做的努力。
了解更多
2023 年 1 月 4 日
女性对癌症护理的满意度较低(今日癌症杂志) Lazarex 癌症基金会首席执行官斯蒂芬妮-里维拉(Stephanie Rivera)谈及她的甲状腺癌诊断、被解雇以及寻找自己的声音。
了解更多
< 时间轴 >
2022 年 10 月 5 日
密苏里州吉拉多角- 吉拉多角附近的一名男子为癌症患者提供免费乘车服务,他现在需要的正是这种服务,而且还需要更多。一家非凡的慈善机构正在挺身而出,让这位志愿者能够继续生活,继续奉献。
了解更多
2022 年 9 月 28 日
纽森州长签署具有里程碑意义的癌症防治法,加州癌症联盟表示庆祝 #SB987
了解更多
2022 年 7 月 27 日
斯蒂芬妮-里维拉(Stephanie Rivera)是 Lazarex 癌症基金会的首席执行官,她将与 Yo 一起讨论基金会如何努力解决少数族裔群体在获得癌症试验方面的差距和障碍。该基金会在改善癌症治疗效果、FDA 癌症临床试验多样性和注册方面发挥着领导作用。
了解更多
2022 年 7 月 17 日
克莱顿女子与罕见癌症抗争。癌症的诊断结果总是令人悲痛欲绝。但对于克莱顿的朗达-朗(Rhonda Long)来说,获得确诊的道路漫长而艰难。由于胆管癌非常罕见,因此并没有很多计划来帮助确诊患者。但 Lazarex 癌症基金会在她开始第二次临床试验时提供了住宿和交通援助。
了解更多
2022 年 5 月 13 日
该组织致力于通过承担费用让更多有色人种参与临床药物试验。 美国食品和药物管理局(FDA)称,有色人种在医学研究中的代表性不足。KOCO 新闻 5
了解更多